{
  "docId": "019de071-4830-7608-84e8-b3f03659010d",
  "docSlug": "f2adf3cca406f89f9f21532698bebce4",
  "documentTitle": "Omega Therapeutics | IPO Presentation Deck | 33 slides",
  "authorId": "omega-therapeutics",
  "authorName": "Omega Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7843866,
  "pageNumber": 21,
  "pageCount": 33,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 40,
  "notes": "The slide compares tumor luminescence (growth) and body weight change (toxicity) across three groups: negative control, OEC candidate, and Sorafenib.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-4830-7608-84e8-b3f03659010d/21",
  "deckHref": "/decks/019de071-4830-7608-84e8-b3f03659010d",
  "deckJsonHref": "/decks/019de071-4830-7608-84e8-b3f03659010d.json",
  "deckAnchorHref": "/decks/019de071-4830-7608-84e8-b3f03659010d#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.52,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Body weight change over time",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "545d3079-93b5-4751-bad2-6ee73c351886",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Tumor growth (luminescence) over time",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ef9c385-459a-41e0-80e7-7635db61743a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.35,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "* Statistically significant vs negative control, t-test p<0.05 ** Sorafenib administered 50 mg/kg po, once daily Arrows denote dosing days",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b653c76f-8fd9-4a72-9d9d-aad8906bd593",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "Inhibition of tumor growth after IV treatment every five days with OEC candidate in HCC orthotopic liver tumor model (Hep3B)",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5f50a254-c436-443c-966c-fa884357064b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.02
      },
      "kind": "title",
      "text": "In vivo PoC Data in Oncology Program - HCC",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fb0ec90-2e8e-4c43-a557-965bc7da7932",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}